Detalhe da pesquisa
1.
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Mult Scler
; 28(9): 1340-1350, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35112578
2.
Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(5)2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37369602
3.
Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study.
Mult Scler Relat Disord
; 70: 104458, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36586351
4.
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Mult Scler Relat Disord
; 68: 104209, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36257152
5.
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 9(5)2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35835563
6.
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis.
Mult Scler Relat Disord
; 56: 103296, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34678704
7.
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.
Neurol Neuroimmunol Neuroinflamm
; 8(5)2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34429340